Bird flu: first ever death from rare H5N5 strain is recorded in US

Washington state officials said an older adult from Grays Harbor County who kept a backyard flock has died after infection with H5N5 avian influenza, the first suspected human case of that strain; the patient was hospitalized in early November with fever, confusion and respiratory symptoms and had underlying conditions. Authorities and the CDC say the risk to the public remains low, no other contacts have tested positive and there is no evidence of human-to-human transmission, while H5N5 is not thought to pose a greater threat than H5N1 (which accounted for about 70 reported human infections in the U.S. in 2024–25). The case underscores continued surveillance needs around poultry exposures and biosecurity on farms and among backyard flocks, even as public-health agencies judge broader public risk unchanged.

Analysis

Washington state health officials reported an older adult from Grays Harbor County who kept a backyard poultry flock is believed to be the first human fatality from H5N5 avian influenza; the patient was hospitalized in early November with high fever, confusion and respiratory problems and had underlying health conditions. State authorities said the flock had been exposed to wild birds and that they will monitor close contacts, but no other people have tested positive and there is no evidence of human-to-human transmission.

The Centers for Disease Control and Prevention stated the single case does not indicate an increased risk to public health and health officials judge H5N5 is not a greater threat to humans than H5N1, which produced roughly 70 reported U.S. human infections in 2024–25. The virological difference cited concerns a protein that affects viral release and local cell spread, a detail that informs scientific surveillance but has not altered public-risk assessments.

Given official assessments the immediate market impact appears limited (market impact score 0.15) but the development reinforces surveillance and biosecurity priorities for poultry and related agricultural operations. Investors should watch for additional cases, shifts in transmission evidence, and any policy or trade responses that could create localized cost or demand impacts for poultry producers, agribusiness suppliers and healthcare/diagnostics vendors.

Key Decisions for Investors

• Monitor CDC and Washington state updates for any evidence of human-to-human transmission or additional cases before changing broad market positions
• Review direct exposure to poultry producers, backyard-flock suppliers and regional agribusinesses and consider short-term hedges if positions are concentrated in those names
• Watch for regulatory, trade or localized containment actions that could affect supply chains or costs for poultry and related feed/processing companies
• Maintain exposure to diversified healthcare and diagnostics names tied to surveillance and response but avoid overreacting to a single, officially assessed low-risk case